Background: Dyslipidemia and hypertension constitute the twin pillars of cardiovascular risk in modern epidemiology. In classical Ayurvedic medicine, hypertension corresponds to the concept of Raktabharadhikyata (excess pressure of blood), while dyslipidemia may be correlated with impaired Meda Dhatu (lipid tissue) metabolism arising from aggravated Kapha and vitiated Vata. Objective: This case study examines the clinical management of a 52-year-old male patient presenting with primary hypertension and mixed dyslipidemia, using a structured regimen of Medhya Rasayana formulations over a 16-week period. Methods: Standardised Ayurvedic formulations including Ashwagandha (Withania somnifera), Brahmi (Bacopa monnieri), Guduchi (Tinospora cordifolia), and Arjuna (Terminalia arjuna) were administered alongside dietary modifications and Panchakarma procedures. Results: Significant improvements were observed in total cholesterol, LDL, HDL, and blood pressure parameters. Conclusion: Medhya Rasayana formulations offer a holistic, evidence-aligned approach to managing cardiometabolic risk with minimal adverse effects.
Dr. Ayasha Nilkanth Raut (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: